Tafoxiparin: Ph IIb started

Dilafor began a double-blind, placebo-controlled, European Phase IIb trial to evaluate 3 dose levels of IV tafoxiparin as an adjunct to oxytocin for up to 36 hours in about 360 term-pregnant, nullipar...